Roctavian Side Effects
Generic name: valoctocogene roxaparvovec
Medically reviewed by Drugs.com. Last updated on Feb 6, 2024.
Note: This document contains side effect information about valoctocogene roxaparvovec. Some dosage forms listed on this page may not apply to the brand name Roctavian.
Applies to valoctocogene roxaparvovec: intravenous suspension.
Serious side effects of Roctavian
Along with its needed effects, valoctocogene roxaparvovec (the active ingredient contained in Roctavian) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking valoctocogene roxaparvovec:
More common
- Back pain
- blurred vision
- chest tightness
- chills
- confusion
- cough
- diarrhea
- difficulty swallowing
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- fast heartbeat
- fever
- flushing
- headache
- hives, itching, skin rash
- nausea and vomiting
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- runny nose
- shivering
- sweating
- tingling of the throat
- trouble breathing
- unusual tiredness or weakness
- watery eyes
Less common
- Loss of appetite
- stomach pain
Incidence not known
- Dark urine
- pains in the chest, groin, or legs, especially the calves of the legs
- severe headaches of sudden onset
- sudden loss of coordination
- sudden onset of slurred speech
- sudden vision changes
- yellow eyes or skin
Other side effects of Roctavian
Some side effects of valoctocogene roxaparvovec may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- General feeling of discomfort or illness
- headache
- unusual drowsiness, dullness, tiredness, weakness or feeling of sluggishness
Less common
- Stomach pain
For Healthcare Professionals
Applies to valoctocogene roxaparvovec: intravenous suspension.
General
The most common adverse reactions with a frequency of 5% or greater were nausea, fatigue, headache, infusion-related reactions, vomiting, and abdominal pain.
The most common laboratory abnormalities with a frequency of 10% or greater were increased alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine phosphokinase (CPK), factor VIII activity levels, gamma-glutamyl transferase (GGT), and bilirubin greater than ULN.[Ref]
Dermatologic
Uncommon (0.1% to 1%): Rash
Frequency not reported: Maculopapular rash[Ref]
Gastrointestinal
Very common (10% or more): Nausea (31%)
Common (1% to 10%): Vomiting, abdominal pain (includes abdominal discomfort, abdominal distension, abdominal tenderness, upper abdominal pain), diarrhea
Uncommon (0.1% to 1%): Gastroenteritis[Ref]
Hepatic
Very common (10% or more): Hepatotoxicity (96%), increased ALT (81%), increased AST (69%), increased GGT (18%), increased bilirubin (13%)[Ref]
Hypersensitivity
Common (1% to 10%): Infusion related reactions, hypersensitivity reactions, anaphylaxis
Frequency not reported: Presyncope[Ref]
Other
Very common (10% or more): Fatigue (includes fatigue, lethargy, and malaise;16%), increased LDH (57%), increased CPK (45%), increased factor VIII activity levels (28%)[Ref]
Psychiatric
Common (1% to 10%): Dizziness[Ref]
Nervous system
Common (1% to 10%): Headache[Ref]
More about Roctavian (valoctocogene roxaparvovec)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- En español
Patient resources
Professional resources
Related treatment guides
References
1. Product Information. Roctavian (valoctocogene roxaparvovec). BioMarin Pharmaceutical Inc. 2023.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.